| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $2.20 ▼ -1.06% | wingi | $2.23 ▲ +0.45% | Sesuk Protalix Bio Therapeutics Inc. (DE) Common Stock (PLX) persiyapan wis anchored kanggo $2.22 lan target $2.20 (-1.06%). Waca sing cedhak yaiku kekurangane; nonton $2.29 / $2.15 amarga volatilitas sing diwujudake saben dina babagan 5.47%. |
Sesuk Protalix Bio Therapeutics Inc. (DE) Common Stock (PLX) persiyapan wis anchored kanggo $2.22 lan target $2.20 (-1.06%). Waca sing cedhak yaiku kekurangane; nonton $2.29 / $2.15 amarga volatilitas sing diwujudake saben dina babagan 5.47%. | ||||
| Minggu | $2.15 ▼ -3.30% | Minggu kepungkur | $2.25 ▲ +1.39% | Model 7 dina Protalix Bio Therapeutics Inc. (DE) Common Stock pindhah saka $2.25 menyang $2.15 (-3.30%). Iku menehi konteks momentum kekurangane kanggo saham iki, supaya break watara $2.29 / $2.15 prakara luwih saka siji obah. |
Model 7 dina Protalix Bio Therapeutics Inc. (DE) Common Stock pindhah saka $2.25 menyang $2.15 (-3.30%). Iku menehi konteks momentum kekurangane kanggo saham iki, supaya break watara $2.29 / $2.15 prakara luwih saka siji obah. | ||||
| wulan | $2.06 ▼ -7.03% | Wulan kepungkur | $2.29 ▲ +2.95% | Target 1 wulan Protalix Bio Therapeutics Inc. (DE) Common Stock yaiku $2.06 (-7.03%), dibandhingake karo referensi langsung ing cedhak $2.22. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan Protalix Bio Therapeutics Inc. (DE) Common Stock yaiku $2.06 (-7.03%), dibandhingake karo referensi langsung ing cedhak $2.22. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $1.94 ▼ -12.62% | Taun kepungkur | $2.34 ▲ +5.30% | Skenario 1 taun Protalix Bio Therapeutics Inc. (DE) Common Stock nuduhake $1.94 (-12.62%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun Protalix Bio Therapeutics Inc. (DE) Common Stock nuduhake $1.94 (-12.62%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $1.65 ▼ -25.71% | 5 Taun kepungkur | $2.46 ▲ +10.80% | Tampilan 5 taun Protalix Bio Therapeutics Inc. (DE) Common Stock yaiku $1.65 (-25.71%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun Protalix Bio Therapeutics Inc. (DE) Common Stock yaiku $1.65 (-25.71%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $2.22 | agêng |
| Ganti saben dina | -2.20% | Ngisor |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 62% | Ngisor |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $2.22 | Ganti saben dina | -2.20% |
| Pasar Kab | $178.87M | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.